LFTD Partners (LIFD) 10-Q 11 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	11-May-15
Document and Entity Information:
Entity Registrant Name	ACQUIRED SALES CORP
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Entity Central Index Key	1391135
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		2,269,648
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

CONDENSED_BALANCE_SHEETS_Unaud

CONDENSED BALANCE SHEETS (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$373,971	$587,937
Prepaid expenses	7,985	7,985
Total Current Assets	381,956	595,922
Note receivable	602,500	602,500
Interest receivable	55,805	35,926
Total Assets	1,040,261	1,234,348
Current Liabilities
Trade accounts payable	48,121	24,982
Total Liabilities	48,121	24,982
Shareholders' Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,269,648 shares outstanding	2,270	2,270
Additional paid-in capital	13,554,524	13,554,524
Accumulated deficit	-12,564,654	-12,347,428
Total Shareholders' Equity	992,140	1,209,366
Total Liabilities and Shareholders' Equity	$1,040,261	$1,234,348

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position
Common Stock, par or stated value	$0.00	$0.00
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares outstanding	2,269,648	2,269,648
Preferred Stock, par or stated value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued
Preferred Stock, shares outstanding

CONDENSED_STATEMENTS_OF_OPERAT

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement
Selling, General and Administrative Expense	($239,372)	($75,345)
Interest Income	19,879
Other Income	2,267
Loss from Continuing Operations	-217,226	-75,345
Gain on Disposal of Discontinued Operations		7,941
Net Income (Loss)	($217,226)	($67,404)
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	($0.10)	($0.03)
Discontinued Operations
Basic and Diluted Earnings (Loss) per Share	($0.10)	($0.03)

CONDENSED_STATEMENTS_OF_SHAREH

CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Stockholders' Equity beginning of period, Value at Dec. 31, 2013	$2,270	$8,410,295	($7,026,157)	$1,386,408
Stockholders' Equity beginning of period, Shares at Dec. 31, 2013	2,269,648
Net loss			-67,404	-67,404
Stockholders' Equity, end of period, Value at Mar. 31, 2014	2,270	8,410,295	-7,093,561	1,319,004
Stockholders' Equity, end of period, Shares at Mar. 31, 2014	2,269,648
Stockholders' Equity beginning of period, Value at Dec. 31, 2014	2,270	13,554,524	-12,347,428	1,209,366
Stockholders' Equity beginning of period, Shares at Dec. 31, 2014	2,269,648
Net loss			-217,226	-217,226
Stockholders' Equity, end of period, Value at Mar. 31, 2015	$2,270	$13,554,524	($12,564,654)	$992,140
Stockholders' Equity, end of period, Shares at Mar. 31, 2015	2,269,648

CONDENSED_STATEMENT_OF_CASH_FL

CONDENSED STATEMENT OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows From Operating Activities
Net income (loss)	($217,226)	($67,404)
Adjustments to reconcile income (loss) to net cash used in operating activities:
(Income) loss from discontinued operations	0	-7,941
Changes in operating assets and liabilities:
Accrued interest receivable	-19,879
Accounts payable	23,139	30,001
Net cash used in operating activities of continuing operations	-213,966	-45,344
Net cash provided by operating activities of discontinued operations		7,941
Net Cash Used in Operating Activities	-213,966	-37,403
Cash Flows from Investing Activities
Proceeds from sale of discontinued operations, net of cash sold		1,000,000
Net Cash Provided by (Used in) Investing Activities		1,000,000
Cash Flow From Financing Activities
Payment of obligation under stock repurchase		-20,000
Net Cash Used in Financing Activities of Continuing Operations		-20,000
Net Increase (Decrease) in Cash	-213,966	942,597
Cash and Cash Equivalents at Beginning of Period	587,937	427,294
Cash and Cash Equivalents at End of Period	$373,971	$1,369,891

Note_1_Basis_of_Presentation_a

Note 1 - Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Notes
Note 1 - Basis of Presentation and Significant Accounting Policies	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation – On February 13, 2012, Acquired Sales Corp (“Acquired Sales”, “AQSP” or the “Company”) purchased 100% of the equity interests of Defense & Security Technology Group, Inc. (“DSTG”). On September 30, 2013, Acquired Sales sold 100% of the capital stock of DSTG to Minh Le, the previous owner of DSTG prior to its acquisition. DSTG’s results of operations have been included in the Company's operations through September 30, 2013 and have been reclassified as discontinued operations.
	On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of Cogility Software Corporation (“Cogility”) to Drumright. Cogility’s results of operations have been reclassified as discontinued operations.
	Condensed Financial Statements – The accompanying financial statements are condensed and do not include all disclosures normally required by generally accepted accounting principles. These statements should be read in conjunction with the annual financial statements included in Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2015. In particular, the nature of operations and significant accounting principles were presented in Note 1 to the annual financial statements. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying unaudited condensed consolidated financial statements and consist of only normal recurring adjustments, except as disclosed herein. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2015.
	Principles of Consolidation – The accompanying consolidated financial statements include the accounts and operations of Acquired Sales for all periods presented. Intercompany accounts and transactions have been eliminated on consolidation.
	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Significant estimates include share-based compensation. Actual results and outcomes may differ from management’s estimates and assumptions.
	Basic and Diluted Earnings (Loss) Per Common Share – Basic earnings (loss) per common share is determined by dividing earnings (loss) by weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is calculated by dividing earnings (loss) by the weighted-average number of common shares and dilutive common share equivalents outstanding during the period. When dilutive, the incremental potential common shares issuable upon exercise of stock options and warrants are determined by the treasury stock method.
	The following table summarizes the calculations of basic and diluted earnings (loss) per share for the three months ended March 31, 2015 and 2014.
		For the Three Months
		Ended
		31-Mar-14
		2015	2014
	Loss from continuing operations	($217,226)	($75,345)
	Income from discontinued operations	-	7,941
	Net income (Loss)	($217,226)	($67,404)
	Weighted -Average Shares Outstanding	2,269,648	2,269,648
	Basic  and Diluted Earnings (Loss) per Share
	Continuing Operations	($0.10)	($0.03)
	Discontinued Operations	-	-
	Basic and Diluted Earnings (Loss) per Share	($0.10)	($0.03)
	There were 6,198,774 stock options and warrants and 938,000 financing warrants outstanding during the three months ended March 31, 2015 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 employee stock options and 938,000 warrants outstanding during the three months ended March 31, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive.
	Recent Accounting Pronouncements - In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The effective date will be the first quarter of fiscal year 2018 using one of two retrospective application methods. The Company has not determined the potential effects on the financial statements.
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition.  The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note_2_Risks_and_Uncertainties

Note 2 - Risks and Uncertainties	3 Months Ended
	Mar. 31, 2015
Notes
Note 2 - Risks and Uncertainties	NOTE 2 - RISKS AND UNCERTAINTIES
	Going Concern – The Company has a history of recurring losses, which have resulted in an accumulated deficit of $12,564,654 as of March 31, 2015. During the three months ended March 31, 2015, the Company recognized a loss of $217,226 from continuing operations. The Company used net cash of $213,966 in operating activities of continuing operations. The sale of Cogility and DSTG eliminated the Company’s source of revenue. As a result, there is substantial doubt that the Company will be able to continue as a going concern. Bankruptcy of the Company at some point in the future is a possibility. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
	Management plans to sustain the Company as a going concern by taking the following actions: (1) acquiring and/or developing profitable businesses that will create positive income from operations; (2) acquiring valuable real estate in exchange for common stock and/or preferred stock; and/or (3) completing private placements of our common stock and/or preferred stock. Management believes that by taking these actions, the Company will be provided with sufficient future operations and cash flow to continue as a going concern. However, there can be no assurance that the Company will be successful in consummating such actions on acceptable terms, if at all. Moreover, any such actions can be expected to result in substantial dilution to the existing shareholders of the Company.

Note_3_Note_Receivable

Note 3 - Note Receivable	3 Months Ended
	Mar. 31, 2015
Notes
Note 3 - Note Receivable	NOTE 3 – NOTE RECEIVABLE
	The William Noyes Webster Foundation, Inc. (the "Foundation"), a non-profit Massachusetts corporation, has received a provisional registration from the Commonwealth of Massachusetts to own and operate a medical marijuana cultivation facility and dispensary in Barnstable County, Massachusetts. Jane W. Heatley ("Heatley") is the founder and a member of the board of directors of the Foundation.
	Teaming Agreement - On July 8, 2014, Acquired Sales Corp. ("AQSP") and Heatley agreed to use their respective best efforts, working exclusively together as a team, and not as a partnership or other entity, in order to consummate transactions, agreements, contracts and other arrangements pursuant to which AQSP will provide capital and expertise to the Foundation.
	Promissory Note - On July 14, 2014, the Foundation signed and delivered to AQSP a Secured Promissory Note (the "Note") which is in the stated loan amount of $1,500,000. The Note provides that the $1,500,000 loan may be advanced in one or more installments as the Foundation and AQSP may mutually agree upon. The Foundation and AQSP mutually agreed that the first installment of this loan would be $602,500. Pursuant to instructions from the Foundation, on July 14, 2014, AQSP paid $2,500 owed by the Foundation to one of its consultants, and AQSP advanced $600,000 directly to the Foundation. The amount and timing of subsequent loan installments under the Note, which could total $897,500, had not yet been mutually agreed upon between the Foundation and AQSP as of the date of the Note.
	The principal balance outstanding under the Note bears interest at the rate of 12.5% per annum, compounded monthly. The Company accrued $55,805 in interest under the note for the period ended March 31, 2015. The first payment of accrued interest by the Foundation under the Note shall be made as soon after the Foundation commences operations of its medical marijuana cultivation facility and dispensary as the Foundation's cash flows shall reasonably permit, but in any event no later than one year after the Foundation commences operations. The principal of the Note shall be payable in eight consecutive equal quarterly installments, commencing on the last day of the calendar quarter in which the Foundation commences operations. Principal on the Note and related accrued interest will be considered past due if the aforementioned payments are not received by their due dates.
	The Company assessed the collectability of the Note based on the adequacy of the Foundation’s collateral and the Foundation’s capability of repaying the Note according to its terms. The Note is secured by, among other things, certain of the Foundation’s assets, as set out in a Security Agreement dated July 14, 2014 (the “Security Agreement”). Based on this assessment, the Company has concluded that no allowance for loan losses was required as of March 31, 2015.

Note_4_Notes_Payable

Note 4 - Notes Payable	3 Months Ended
	Mar. 31, 2015
Notes
Note 4 - Notes Payable	NOTE 4 – NOTES PAYABLE
	Notes Payable to Related Parties – On July 14, 2014, AQSP borrowed $300,000 from the Roberti Jacobs Family Trust (the "Trust"). The Trust is an affiliate of Gerard M. Jacobs, AQSP's chief executive officer.  The loan was repaid in full on August 5, 2014.

Note_5_Shareholders_Equity

Note 5 - Shareholders' Equity	3 Months Ended
	Mar. 31, 2015
Notes
Note 5 - Shareholders' Equity	NOTE 5 – SHAREHOLDERS’ EQUITY
	Share-Based Compensation –
	The following is a summary of share-based compensation, stock option and warrant activity as of March 31, 2015 and changes during the year then ended:
			Weighted-Average	Weighted-Average	Aggregate
				Remaining Contractual	Intrinsic
		Shares	Exercise Price (a)	Term (Years)	Value
	Outstanding, December 31, 2014	6,198,774	$1.56
	Granted in Q1 2015	-	-
	Outstanding, March 31, 2015	6,198,774	$1.56	7.9	$6,379,269
	Exercisable, March 31, 2015	3,598,774	$1.46	6.55	$5,266,769
	Note:
	(a) The Weighted-Average Exercise Price column excludes those warrants that have an exercise price for the common stock priced at the Capital Raise Price Per Share.
	Financing Warrants – Through December 31, 2012, the Company issued 938,000 warrants in connection with the issuance of notes payable primarily to related parties. The warrants were outstanding at March 31, 2015. At March 31, 2015, the financing warrants had a weighted-average exercise price of $2.32 per share, a weighted-average remaining contractual term of 1.85 years and an aggregate intrinsic value of $525,400.
	Common Stock – On October 17, 2013, the Company entered into a settlement agreement with Matthew Ghourdjian and the Deborah Sue Ghourdjian Separate Property Trust, whereby Mr. Ghourdjian and the Trust sold to the Company 690,796 shares of common stock for $30,000 cash plus an obligation to pay an additional $20,000 in February 2014, or approximately $0.07 per share. Mr. Ghourdjian resigned from the Company as an employee, director and officer. Mr. Ghourdjian and the Trust, and the Company entered into mutual releases of all claims against one another. The obligation was paid in February 2014.
	Also on October 17, 2013, Mr. Roger Greene entered into a settlement agreement with the Company whereby Mr. Greene forfeited his options to purchase 25,000 shares of common stock of the Company at $0.001 per share. In addition, Mr. Greene and the Company signed mutual releases of any and all claims against one another. Mr. Greene resigned as a director of the Company on that date.

Note_6_Contingent_Contractual_

Note 6 - Contingent Contractual Obligations and Commercial Commitments	3 Months Ended
	Mar. 31, 2015
Notes
Note 6 - Contingent Contractual Obligations and Commercial Commitments	NOTE 6 – CONTINGENT CONTRACTUAL OBLIGATIONS AND COMMERCIAL COMMITMENTS
	As discussed in Note 3, the Company has commitments under agreements with the William Noyes Webster Foundation, Inc.
	Medical marijuana on Cape Cod:
	AQSP has agreed to pay a lump sum finder's fee to Parare Partners Inc. in the event that all of the following conditions occur: (1) AQSP makes certain loans to the William Noyes Webster Foundation, Inc. (the "Foundation") which was found by Parare
	Partners Inc., (2) the Foundation constructs and brings into operation its planned medical marijuana cultivation facility and dispensary in Massachusetts, (3) AQSP directly or via subsidiaries enters into certain consulting agreements with the Foundation, and (4) all necessary approvals are obtained. If all of such conditions occur, then the finder's fee will be calculated as follows: (i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
	Medical marijuana in California and Oregon:
	AQSP has agreed to pay a lump sum finder’s fee to Parare Partners Inc. in the event that all of the following conditions occur: (1) AQSP makes certain loans to a company found by Parare Partners Inc. (the "Cal/Ore Company") that wants to purchase certain medical marijuana facilities in  California and Oregon (the "Cal/Ore Facilities"), (2) the Cal/Ore Company purchases the Cal/Ore Facilities, (3) AQSP directly or via subsidiaries enters into purchase agreements with the Cal/Ore Company regarding the Cal/Ore Facilities, and (4) all necessary approvals are obtained. If all of such conditions occur, then the finder's fee will be calculated as follows: (i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
	As of March 31, 2015, no finder’s fees are due to Parare Partners, Inc.
	Financial Consulting Agreement:
	In January 2015, AQSP retained Aspen Equity Partners, LLL (“Aspen”) as  AQSP’s financial advisor, and AQSP paid Aspen a nonrefundable retainer of $50,000 in connection therewith. As AQSP’s financial advisor, Aspen may assist AQSP in the placement of equity, equity-linked securities or debt securities of the Company.  If AQSP completes  an equity financing covered by its agreement with Aspen, then Aspen shall receive a fee from AQSP of between three and one half percent (3.5%) to seven percent (7%) of the amount of such equity financing.  If AQSP completes a debt financing covered by its agreement with Aspen, then Aspen shall receive a fee of between one half percent (0.5%) to one percent (1%) of the amount of such debt financing. In addition, if AQSP completes an equity financing or a debt financing covered by its agreement with Aspen, then Aspen shall receive an additional transaction fee consisting of warrants to purchase the Company’s common stock so that, after giving effect to such financing, Aspen shall hold warrants equal to five percent (5%) of the equity financing or three percent (3%) of the debt financing. The period of time during which Aspen is obligated to provide financial advisory services to AQSP ends on May 31, 2015.

Note_7_Subsequent_Events

Note 7 - Subsequent Events	3 Months Ended
	Mar. 31, 2015
Notes
Note 7 - Subsequent Events	NOTE 7 – SUBSEQUENT EVENTS
	We have evaluated subsequent events through the date of filing this quarterly report on Form 10-Q.
	AQSP has made additional loans of $71,950 to the Foundation subsequent to the quarter-end date. Following such additional loans, the principal of the loan from AQSP to the Foundation, evidenced by the Note and secured by the Security Agreement, is now $674,450.

Note_1_Basis_of_Presentation_a1

Note 1 - Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Policies
Basis of Presentation	Basis of Presentation – On February 13, 2012, Acquired Sales Corp (“Acquired Sales”, “AQSP” or the “Company”) purchased 100% of the equity interests of Defense & Security Technology Group, Inc. (“DSTG”). On September 30, 2013, Acquired Sales sold 100% of the capital stock of DSTG to Minh Le, the previous owner of DSTG prior to its acquisition. DSTG’s results of operations have been included in the Company's operations through September 30, 2013 and have been reclassified as discontinued operations.
	On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of Cogility Software Corporation (“Cogility”) to Drumright. Cogility’s results of operations have been reclassified as discontinued operations.
Condensed Financial Statements	Condensed Financial Statements – The accompanying financial statements are condensed and do not include all disclosures normally required by generally accepted accounting principles. These statements should be read in conjunction with the annual financial statements included in Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2015. In particular, the nature of operations and significant accounting principles were presented in Note 1 to the annual financial statements. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying unaudited condensed consolidated financial statements and consist of only normal recurring adjustments, except as disclosed herein. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2015.
Principles of Consolidation	Principles of Consolidation – The accompanying consolidated financial statements include the accounts and operations of Acquired Sales for all periods presented. Intercompany accounts and transactions have been eliminated on consolidation.
Use of Estimates	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Significant estimates include share-based compensation. Actual results and outcomes may differ from management’s estimates and assumptions.
Basic and Diluted Earnings (Loss) Per Common Share	Basic and Diluted Earnings (Loss) Per Common Share – Basic earnings (loss) per common share is determined by dividing earnings (loss) by weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is calculated by dividing earnings (loss) by the weighted-average number of common shares and dilutive common share equivalents outstanding during the period. When dilutive, the incremental potential common shares issuable upon exercise of stock options and warrants are determined by the treasury stock method.
	The following table summarizes the calculations of basic and diluted earnings (loss) per share for the three months ended March 31, 2015 and 2014.
		For the Three Months
		Ended
		31-Mar-14
		2015	2014
	Loss from continuing operations	($217,226)	($75,345)
	Income from discontinued operations	-	7,941
	Net income (Loss)	($217,226)	($67,404)
	Weighted -Average Shares Outstanding	2,269,648	2,269,648
	Basic  and Diluted Earnings (Loss) per Share
	Continuing Operations	($0.10)	($0.03)
	Discontinued Operations	-	-
	Basic and Diluted Earnings (Loss) per Share	($0.10)	($0.03)
	There were 6,198,774 stock options and warrants and 938,000 financing warrants outstanding during the three months ended March 31, 2015 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 employee stock options and 938,000 warrants outstanding during the three months ended March 31, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements - In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The effective date will be the first quarter of fiscal year 2018 using one of two retrospective application methods. The Company has not determined the potential effects on the financial statements.
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition.  The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note_1_Basis_of_Presentation_a2

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)	3 Months Ended
	Mar. 31, 2015
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	The following table summarizes the calculations of basic and diluted earnings (loss) per share for the three months ended March 31, 2015 and 2014.
		For the Three Months
		Ended
		31-Mar-14
		2015	2014
	Loss from continuing operations	($217,226)	($75,345)
	Income from discontinued operations	-	7,941
	Net income (Loss)	($217,226)	($67,404)
	Weighted -Average Shares Outstanding	2,269,648	2,269,648
	Basic  and Diluted Earnings (Loss) per Share
	Continuing Operations	($0.10)	($0.03)
	Discontinued Operations	-	-
	Basic and Diluted Earnings (Loss) per Share	($0.10)	($0.03)

Note_5_Shareholders_Equity_Sch

Note 5 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Tables)	3 Months Ended
	Mar. 31, 2015
Tables/Schedules
Schedule of Share-based Compensation, Stock Options and Warrant Activity	The following is a summary of share-based compensation, stock option and warrant activity as of March 31, 2015 and changes during the year then ended:
			Weighted-Average	Weighted-Average	Aggregate
				Remaining Contractual	Intrinsic
		Shares	Exercise Price (a)	Term (Years)	Value
	Outstanding, December 31, 2014	6,198,774	$1.56
	Granted in Q1 2015	-	-
	Outstanding, March 31, 2015	6,198,774	$1.56	7.9	$6,379,269
	Exercisable, March 31, 2015	3,598,774	$1.46	6.55	$5,266,769
	Note:
	(a) The Weighted-Average Exercise Price column excludes those warrants that have an exercise price for the common stock priced at the Capital Raise Price Per Share.

Note_1_Basis_of_Presentation_a3

Note 1 - Basis of Presentation and Significant Accounting Policies: Basis of Presentation (Details)	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2013	Jan. 12, 2013
Defense Securities Technology Group
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	100.00%
Defense & Security Technology Group, Inc
Stock Sold to Acquirer, percent		100.00%
Drumright Group LLC purchase of Cogility
Stock Sold to Acquirer, percent			100.00%

Note_1_Basis_of_Presentation_a4

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Details
Loss from Contining Operations	($217,226)	($75,345)
Income from Discontinued Operations	0	7,941
Net income (Loss)	($217,226)	($67,404)
Weighted -Average Shares Outstanding	2,269,648	2,269,648
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	($0.10)	($0.03)
Discontinued Operations
Basic and Diluted Earnings (Loss) per Share	($0.10)	($0.03)

Note_1_Basis_of_Presentation_a5

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Equity Option
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,198,774	2,148,774
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	938,000	938,000

Note_2_Risks_and_Uncertainties1

Note 2 - Risks and Uncertainties (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Details
Accumulated deficit	($12,564,654)		($12,347,428)
Loss from Contining Operations	-217,226	-75,345
Net cash used in operating activities of continuing operations	($213,966)	($45,344)

Note_3_Note_Receivable_Details

Note 3 - Note Receivable (Details) (USD $)	1 Months Ended
	Jul. 31, 2014	Mar. 31, 2015	Dec. 31, 2014
Accrued Interest Receivable		$55,805	$35,926
Secured Promissory Note | William Noyes Webster Foundation Inc
Debt Instrument, Face Amount		1,500,000
Note Receivable		602,500
Advances	600,000
Debt Instrument, Interest Rate, Stated Percentage		12.50%
Secured Promissory Note | William Noyes Webster Foundation Inc | Payment To Consultant
Advances	2,500
Secured Promissory Note | William Noyes Webster Foundation Inc | Unfunded Portion of Note
Debt Instrument, Face Amount		$897,500

Note_4_Notes_Payable_Details

Note 4 - Notes Payable (Details) (Roberti Jacobs Family Trust, USD $)	Jul. 14, 2014
Roberti Jacobs Family Trust
Debt Instrument, Face Amount	$300,000

Note_5_Shareholders_Equity_Sch1

Note 5 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Details
Options, Outstanding, Beginning Balance	6,198,774
Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$1.56
Granted in Q1 2015	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$0
Options, Outstanding, Ending Balance	6,198,774
Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$1.56
Options, Outstanding, Weighted Average Remaining Term	7 years 10 months 24 days
Options, Outstanding, Intrinsic Value	$6,379,269
Options, Exercisable	3,598,774
Options, Exercisable, Weighted Average Exercise Price	$1.46
Options, Exercisable, Weighted Average Remaining Term	6 years 6 months 18 days
Options, Exercisable, Intrinsic Value	$5,266,769

Note_5_Shareholders_Equity_Det

Note 5 - Shareholders' Equity (Details) (USD $)	3 Months Ended	12 Months Ended	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Feb. 28, 2014	Oct. 17, 2013
Class of Warrant, Outstanding			938,000
Class of Warrant, Exercise Price of Warrants			2.32
Payment to Mr. Ghourdjian for Purchase of Common Stock	$20,000	$30,000
Payment to Mr. Ghourdjian for Purchase of Common Stock	20,000	30,000
Matthew Ghourdjian
Share Price				$0.07
Roger Greene
Share Price					$0.00
Options, Forfeited in Period			25,000
Common Stock
Stock Repurchased During Period, Shares		-690,796
Warrant | Notes Payable to Related Parties
Weighted Average Remaining Contractual Term			1 year 10 months 6 days
Aggregate Intrinsic Value			525,400

Note_6_Contingent_Contractual_1

Note 6 - Contingent Contractual Obligations and Commercial Commitments (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Parere Partners Inc. | Medical marijuana on Cape Cod
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	(i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
Parere Partners Inc. | Medical marijuana in California and Oregon
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	(i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
Aspen Equity Partners, LLL | Financial Consulting Agreement
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	If AQSP completes an equity financing covered by its agreement with Aspen, then Aspen shall receive a fee from AQSP of between three and one half percent (3.5%) to seven percent (7%) of the amount of such equity financing. If AQSP completes a debt financing covered by its agreement with Aspen, then Aspen shall receive a fee of between one half percent (0.5%) to one percent (1%) of the amount of such debt financing. In addition, if AQSP completes an equity financing or a debt financing covered by its agreement with Aspen, then Aspen shall receive an additional transaction fee consisting of warrants to purchase the Company’s common stock so that, after giving effect to such financing, Aspen shall hold warrants equal to five percent (5%) of the equity financing or three percent (3%) of the debt financing.
Nonrefundable Retainer	50,000

Note_7_Subsequent_Events_Detai

Note 7 - Subsequent Events (Details) (Secured Promissory Note, William Noyes Webster Foundation Inc, USD $)	1 Months Ended	3 Months Ended
	Jul. 31, 2014	Mar. 31, 2015
Advances	$600,000
Debt Instrument, Face Amount		1,500,000
Subsequent Event
Advances		71,950
Debt Instrument, Face Amount		$674,450